Miltenyi Biomedicine GmbH
Overview
Miltenyi Biomedicine develops and advances CAR-T therapies for oncology and autoimmune disorders, focusing on clinical programs and manufacturing technology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Miltenyi Biomedicine GmbH in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.